|
1
|
Brennan B: Nasopharyngeal carcinoma.
Orphanet J Rare Dis. 1:232006.
|
|
2
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006.
|
|
3
|
Fang W, Li X, Jiang Q, et al:
Transcriptional patterns, biomarkers and pathways characterizing
nasopharyngeal carcinoma of Southern China. J Transl Med.
6:322008.
|
|
4
|
Young JL Jr and Miller RW: Incidence of
malignant tumors in U.S. Children. J Pediatr. 86:254–258. 1975.
|
|
5
|
Joensuu H: Systemic chemotherapy for
cancer: from weapon to treatment. Lancet Oncol. 9:3042008.
|
|
6
|
Al-Sarraf M: Head and neck cancer:
chemotherapy concepts. Semin Oncol. 15:70–85. 1988.
|
|
7
|
Jacobs C, Lyman G, Velez-García E, Sridhar
KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, et
al: A phase III randomized study comparing cisplatin and
fluorouracil as single agents and in combination for advanced
squamous cell carcinoma of the head and neck. J Clin Oncol.
10:257–263. 1992.
|
|
8
|
Foo KF, Tan EH, Leong SS, Wee JT, Tan T,
Fong KW, Koh L, Tai BC, Lian LG and Machin D: Gemcitabine in
metastatic nasopharyngeal carcinoma of the undifferentiated type.
Ann Oncol. 13:150–156. 2002.
|
|
9
|
Rosenberg B, Vancamp L, Trosko JE and
Mansour VH: Platinum compounds: a new class of potent antitumour
agents. Nature. 222:385–386. 1969.
|
|
10
|
Heidelberger C, Chaudhuri NK, Danneberg P,
et al: Fluorinated pyrimidines, a new class of tumour-inhibitory
compounds. Nature. 179:663–666. 1957.
|
|
11
|
Santi DV, McHenry CS and Sommer H:
Mechanism of interaction of thymidylate synthetase with
5-fluorodeoxyuridylate. Biochemistry. 13:471–481. 1974.
|
|
12
|
Sommer H and Santi DV: Purification and
amino acid analysis of an active site peptide from thymidylate
synthetase containing covalently bound 5-fluoro-20-deoxyuridylate
and methylenetetrahydrofolate. Biochem Biophys Res Commun.
57:689–695. 1974.
|
|
13
|
Maxwell PJ, Longley DB, Latif T, et al:
Identification of 5-fluorouracil-inducible target genes using cDNA
microarray profiling. Cancer Res. 63:4602–4606. 2003.
|
|
14
|
Mauritz R, van Groeningen CJ, Smid K, et
al: Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA
expression after administration of 5-fluorouracil to patients with
colorectal cancer. Int J Cancer. 120:2609–2612. 2007.
|
|
15
|
Shah MY, Pan X, Fix LN, Farwell MA and
Zhang B: 5-Fluorouracil drug alters the microRNA expression
profiles in MCF-7 breast cancer cells. J Cell Physiol.
226:1868–1878. 2011.
|
|
16
|
Zhang BH, Pan XP, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007.
|
|
17
|
Zhang BH, Stellwag EJ and Pan XP:
Large-scale genome analysis reveals unique features of microRNAs.
Gene. 443:100–109. 2009.
|
|
18
|
Koturbash I, Zemp FJ, Pogribny I and
Kovalchuk O: Small molecules with big effects: the role of the
microRNAome in cancer and Carcinogenesis. Mutat Res. 722:94–105.
2011.
|
|
19
|
Meng F, Henson R, Lang M, et al:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006.
|
|
20
|
Xia L, Zhang D, Du R, et al: miR-15b and
miR-16 modulate multidrug resistance by targeting BCL2 in human
gastric cancer cells. Int J Cancer. 123:372–379. 2008.
|
|
21
|
Kovalchuk O, Filkowski J, Meservy J, et
al: Involvement of microRNA-451 in resistance of the MCF-7 breast
cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther.
7:2152–2159. 2008.
|
|
22
|
Rossi L, Bonmassar E and Faraoni I:
Modification of miR gene expression pattern in human colon cancer
cells following exposure to 5-fluorouracil in vitro. Pharmacol Res.
56:248–253. 2007.
|
|
23
|
Duan D, Zheng KX, Shen Y, et al:
Label-free high-throughput microRNA expression profiling from total
RNA. Nucleic Acids Res. 39:e1542011.
|
|
24
|
Park SY, Lee JH, Ha M, et al: miR-29
miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct
Mol Biol. 16:23–29. 2009.
|
|
25
|
Reina Ortiz M, Schreiber F, Benitez S, et
al: Effects of chronic ascariasis and trichuriasis on cytokine
production and gene expression in human blood: a cross-sectional
study. PLoS Neql Trop Dis. 5:e11572011.
|
|
26
|
Xie YF, Shu R, Jiang SY, et al: Comparison
of microRNA profiles of human periodontal diseased and healthy
gingival tissues. Int J Oral Sci. 3:125–134. 2011.
|
|
27
|
Tian RQ, Wang XH, Hou LJ, et al:
MicroRNA-372 is down-regulated and targets cyclin-dependent kinase
2 (CDK2) and cyclin A1 in human cervical cancer, which may
contribute to tumorigenesis. J Biol Chem. 286:25556–25563.
2011.
|
